Anti glomerular basement membrane disease in a renal transplant patient with Alport syndrome;Enfermedad antimembrana basal glomerular en un paciente trasplantado renal con enfermedad de Alport

Medicina

Volumn 59, Issue 5 I, 1999, Pages 466-468

  Pujol, Gervasio Soler ^a   Iotti, Roberto ^a   Michel, Mario Davalos ^a   Turner, A Neil ^a,b   Vilches, Antonio R ^a,c  

^a Ctro de Educacion Medica Invest C   (Argentina)

^b ROYAL INFIRMARY OF EDINBURGH   (United Kingdom)

^c NONE   (Argentina)

Author keywords

Alport syndrome; Anti GBM disease; Plasmapheresis; Renal transplantation

Indexed keywords

ADULT; ARTICLE; CASE REPORT; GLOMERULONEPHRITIS; GRAFT REJECTION; HUMAN; KIDNEY TRANSPLANTATION; MALE; NEPHRITIS; PLASMAPHERESIS;

ADULT; ANTI-GLOMERULAR BASEMENT MEMBRANE DISEASE; GRAFT REJECTION; HUMANS; KIDNEY TRANSPLANTATION; MALE; NEPHRITIS, HEREDITARY; PLASMAPHERESIS;

EID: 0042705417     PISSN: 00257680     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Brainwood D, Kasthtan C, Gubler MC, Turner A. N Targets of alloantibodies in Alport anti-glomerular basement membrane disease after renal transplantation. Kidney Int 1998; 53: 762-6.
2. Feingold J, Bois E, Chompret A, Broyer M, Gubler MC, Grunfeld JP. Genetic heterogeneity of Alport syndrome. Kidney Int 1985; 27: 672-7.
3. Szpiro-Tapia S, Bobrie G, Gouilloud-Bataille M, et al. Linkage studies in X-linked Alport's syndrome. Hum Genet 1988; 81: 85-7.
4. Kleppel MM, Kashtan C, Santi PA; Wieslander J, Michael AF. Distribution of familial nephritis antigen in normal tissue and renal basement membranes of patients with homozygous and heterozygous Alport familial nephritis: Relationship of familial nephritis and Goodpasture antigens to novel collagen chains and type IV collagen. Lab Invest 1989; 61: 278-89.
5. Yoshioka K, Hino S, Takemura T, et al. Type IV colagen α5 chain: Normal distribution and abnormalities in X-linked Alport syndrome revealed by monoclonal antibody. Am J Pathol 1994; 144: 986-96.
6. Kashtan CE, Kim Y: Distribution of the α1 y α2 chains of collagen IV and of collagens V and VI in Alport syndrome. Kidney Int 1992; 42: 115-26.
7. Nakanishi K, Yoshikawa N, Iijima K, et al. Immunohistochemical study of the α1-5 chains of type IV collagen in hereditary nephritis. Kidney Int 1994; 46: 1413-21.
8. Reeders ST: Molecular genetics of hereditary nephritis. Kidney Int 1992; 42: 783-92.
9. Milliner DS, Pierides AM, Holley KE. Renal Transplantation in Alport's Syndrome. Mayo Clin Proc 1982; 57: 35-43.
10. Kashtan CE, Michael AF. Alport syndrome: From bedside to genome to bedside. Am J Kid Dis 1993; 22: 627-40.
11. Hudson BG, Kalluri R, Stripad G, et al. The pathogenesis of Alport syndrome involves type IV collagen molecules containing the α3 (IV) chain: evidence from anti GBM nephritis after renal transplantation. Kidney Int 1992; 42: 179-87.
12. Kashtan C, Fish AJ, Klepper M, Yoshioka K, Michael AF. Nephritogenic antigen determinants in epidermal and renal basement membranes of kindreds with Alport-type familial nephritis. J Clin Invest 1986; 78: 1035-44.
13. Van de Heuvel LPWJ, Schroder CH, Savage COS, et al. The development of anti glomerular basement membrane nephritis in two children with Alport's syndrome after renal transplantation: characterization of the antibody target. Pediatr Nephrol 1989; 3: 406-13.
14. Kashtan C, Butkowski R, Klepper M, First M, Michael A. Post transplant anti-glomerular basement membrane nephritis in related Alport males with Alport syndrome. J Lab Clin Med 1990; 116: 508-15.
15. Ding J, Kashtan CE, Fan WW, et al. A monoclonal antibody marker for Alport syndrome identifies the Alport antigen as the α5 chain of type IV collagen. Kidney Inf 1994; 45: 1504-6.
16. Kashtan CE, Michael AF: Alport syndrome. Kidney Int 1996; 50: 1445-63.
17. Ding J, Zhou J, Trygguason K, Kashtan CE. Colmas deletions in three patients with Alport syndrome and post transplant anti glomerular baseement membrane nephritis. J Am Soc Nephrol 1994; 5: 161-8.